PU
Pulmatrix, Inc.
PULM · NASDAQ
$1.48 -0.66% (-$0.01)
1M -11.46%
Market Cap $4.97M
P/E Ratio -
Div. Yield -
ROE 109.26%
Piotroski F-Score Weak
1/9Valuation
89 /100
Cheap P/B 1.94x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 50.34%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 160.81%
Asset turnover 0.00x
ROE 109.26%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.70x
Int. coverage N/A
Stability
31 /100
Unstable Beta 1.90x
Profitable years 0
Rev. volatility 65.91%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PULM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Ludlum
Employees
2
Headquarters
Framingham
Upcoming events
05 NOV
Earnings
Upcoming earnings report